Navigation Links
Novartis highlights extensive data on numerous compounds at ASCO in multiple cancers, including Phase III studies in GIST and myelofibrosis
Date:5/31/2011

th SEGA include mouth ulcers, infections of the respiratory tract, sinuses and ears and fever.

Please see full Prescribing Information for AFINITOR.

# Rapamune® (sirolimus) and Torisel® (temsirolimus) are registered trademarks of Wyeth Pharmaceuticals Inc.

About SOM230 (pasireotide)SOM230 is an investigational multireceptor targeting somatostatin analog (SSA) that binds to four of the five somatostatin receptor subtypes (sst 1, 2, 3 and 5).

Because it is an investigational compound, the tolerability and efficacy profile of SOM230 has not yet been fully established. Access to this investigational compound is available only through carefully controlled and monitored clinical trials. These trials are designed to better understand the potential benefits and risks of the compound. There is no guarantee that SOM230 will become commercially available.

Information about Novartis clinical trials for SOM230 can be obtained by healthcare professionals at www.pasporttrials.com.

Disclaimer The foregoing release contains forward-looking statements that can be identified by terminology such as "pipeline," "will," "commitment," "potential," or similar expressions, or by express or implied discussions regarding potential new products, potential new indications for existing products, or regarding potential future revenues from any such products. You should not place undue reliance on these statements. Such forward-looking statements reflect the current views of management regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantee that any new products will be submitted or approved for sale in any market, or that any new indications will be submitted or approved for existin
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
2. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
3. Emisphere Announces Recruitment of Novartis Phase III Study for Oral Osteoporosis Treatment
4. Video: Novartis Vaccines and PTA Battle Flu: Public Health Vaccination Initiative Urges Families Lets Fight Flu Together!
5. More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies
6. Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types
7. Juvenile Diabetes Research Foundation, The Genomics Institute of the Novartis Research Foundation Announce Innovative Diabetes Drug Discovery and Development Partnership
8. US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease
9. Results In The New England Journal Of Medicine Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery
10. Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia
11. Novartis Pharmaceuticals Corporation Prevails in Medicaid Pricing Case Before Alabama Supreme Court
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... May 21, 2015  Juniper Pharmaceuticals, Inc. (Nasdaq: ... focused on developing therapeutics that address unmet medical ... Frank Condella will present at the ... Thursday, June 4, 2015Time: , 1:00 PM EDTLocation: ... www.juniperpharma.com, under  ,Investor, or  click here ...
(Date:5/21/2015)... 21, 2015 Omnicell, Inc. , (NASDAQ: ... its Unity enterprise platform, the premier medication and supply ... patient care venues throughout hospitals and health care systems. ... the Epic electronic health record (EHR) and the Omnicell ... needs of health care providers. Through a partnership with ...
(Date:5/21/2015)... Calif. , May 21, 2015 ... that while two-thirds of laboratories use commercial software ... remaining one-third represents uncaptured market share for suppliers. ... category developing custom systems in-house, it is clear ... marketplace. This indicates that suppliers have a chance ...
Breaking Medicine Technology:Juniper Pharmaceuticals to Present at Jefferies 2015 Global Healthcare Conference on June 4, 2015 2Omnicell Enhances Unity Enterprise Platform to Allow Increased Interoperability for Hospitals and Health Systems 2Omnicell Enhances Unity Enterprise Platform to Allow Increased Interoperability for Hospitals and Health Systems 3Omnicell Enhances Unity Enterprise Platform to Allow Increased Interoperability for Hospitals and Health Systems 4Customers' Unmet Needs Create Opportunities for Laboratory Information Management System Suppliers to Transform the Industry 2Customers' Unmet Needs Create Opportunities for Laboratory Information Management System Suppliers to Transform the Industry 3Customers' Unmet Needs Create Opportunities for Laboratory Information Management System Suppliers to Transform the Industry 4
(Date:5/21/2015)... Florida (PRWEB) May 21, 2015 How do ... million dollar question for parents and school administrators, but a ... removal company based in southern Florida, is devising new ... and lice professionals will tell you, the first step is ... daycares and classrooms, head lice and how they spread are ...
(Date:5/21/2015)... New York (PRWEB) May 21, 2015 ... Atmananda Yoga Studio and Sequence, is excited to ... Yoga Mat™, which was previously available for use exclusively ... Yoga Mat™ unique is that it's mathematically designed ... serious joint injuries and muscle strains, commonly experienced ...
(Date:5/21/2015)... Colorado (PRWEB) May 21, 2015 ... American Hemp Exchange, the first fully electronic marketplace ... provide a comprehensive electronic marketplace in which wholesale ... or exchange their hemp-related inventories on a fully ... to meet this demand through a unique blend ...
(Date:5/21/2015)... PharmApprove – the leading strategic, ... biotechnology industries – will be presenting an interactive discussion ... in Philadelphia, PA. PharmApprove’s session, titled “Approval ? ... take place on June 16th at 10:15 am. ... CSO, will moderate the group, which includes Steffen Thirstrup, ...
(Date:5/21/2015)... 2015 Neogenis Labs , a world ... has been named to the 2015 Austin A-List by the ... South by Southwest Interactive. , The A-List companies , ... 275 nominations, were officially revealed and named to the annual ... at ACL-Live. The 12 honorees for 2015 were named in ...
Breaking Medicine News(10 mins):Health News:Local Lice Removal Company Partners with Schools to Combat Head Lice in the Classroom as Increase in Number of Cases Reported in May. 2Health News:NY's Atmananda Yoga Studio Launches Its Patented "Alignment" Yoga Mat for Public Sale 2Health News:Amercanex is Revolutionizing Order and Efficiency in the Hemp Industry 2Health News:PharmApprove Panel at BIO Addresses Success in Drug Development Beyond Regulatory Approval 2Health News:PharmApprove Panel at BIO Addresses Success in Drug Development Beyond Regulatory Approval 3Health News:Neogenis® Labs Named to 2015 Austin A-List Most Promising Startups 2Health News:Neogenis® Labs Named to 2015 Austin A-List Most Promising Startups 3
... Oct. 5 (HealthDay News) -- People who followed the Mediterranean ... whole grains, fish and nuts, were less likely to develop ... a relative reduction in risk of 42 percent to 51 ... preventive medicine at the University of Navarra. "This is a ...
... population in October, November would blunt pandemic, , MONDAY, ... the H1N1 pandemic swine flu, vaccination should start as ... "Earlier -- October versus November -- vaccination saves more ... Dr. Nayer Khazeni, from the division of pulmonary and ...
... ... for rapid expansion and competitive advantage , ... Pittsburgh, PA (PRWEB) October 5, 2009-- BodyMedia, Inc. , the pioneer in ... Calorie Management System by Ki Performance. Through the company,s first strategic partner in Europe, ...
... Health Care is one of only six health care ... School of Medicine and Johns Hopkins University to participate ... health care for senior citizens nationwide by applying best ... ) , "We selected Aurora Health Care because of ...
... Fred Hutchinson Cancer Research Center, Group Health Research Institute ... and Pharmacy have been selected to lead four projects ... for comparative-effectiveness research in cancer. The grants establish Seattle ... aims to objectively analyze cancer diagnostic tools, screening tests ...
... Empire BlueCross BlueShield (Empire) proudly announced today that it will be ... which will be held in New York City from August 26 ... of health and wellness activities around Empire,s 75(th) Anniversary this year. ... the men and women around the world who are there for ...
Cached Medicine News:Health News:Mediterranean Diet May Help Prevent Depression 2Health News:Mediterranean Diet May Help Prevent Depression 3Health News:Early H1N1 Vaccination Saves Lives, Cuts Costs: Study 2Health News:Early H1N1 Vaccination Saves Lives, Cuts Costs: Study 3Health News:BodyMedia, Inc. Expands Overseas Offerings and Receives Milestone Certification for Continued Global Growth 2Health News:BodyMedia, Inc. Expands Overseas Offerings and Receives Milestone Certification for Continued Global Growth 3Health News:Aurora Health Care Among Six Sites Chosen for National Medicare Collaborative on Geriatric Care 2Health News:Aurora Health Care Among Six Sites Chosen for National Medicare Collaborative on Geriatric Care 3Health News:Aurora Health Care Among Six Sites Chosen for National Medicare Collaborative on Geriatric Care 4Health News:$16 Million in Federal Stimulus Funding Establishes Seattle as a Hub of Comparative-Effectiveness Research In Cancer 2Health News:$16 Million in Federal Stimulus Funding Establishes Seattle as a Hub of Comparative-Effectiveness Research In Cancer 3Health News:$16 Million in Federal Stimulus Funding Establishes Seattle as a Hub of Comparative-Effectiveness Research In Cancer 4Health News:$16 Million in Federal Stimulus Funding Establishes Seattle as a Hub of Comparative-Effectiveness Research In Cancer 5Health News:$16 Million in Federal Stimulus Funding Establishes Seattle as a Hub of Comparative-Effectiveness Research In Cancer 6Health News:Empire BlueCross BlueShield to Support 2011 World Police & Fire Games in NYC 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: